Study Title
Open Access Protocol of Targeted Radiotherapy With I-metaiodobenzylguanidine (I-MIBG) in Patients With Resistant Neuroblastoma or Malignant Chromaffin Cell Tumors
Study Details
Description:
The purpose of this research study is to find how active and safe 131 I-MIBG is in patients with resistant neuroblastoma, malignant pheochromocytoma and malignant paraganglioma.
Sponsor:
Memorial Sloan Kettering Cancer Center
Government Study Link:
NCT00107289 - Click here to see study onClinicalTrials.gov
